Journal of Dermatological Treatment · 2012 · 32 citations · 23 references
MedicineDermatologyImmunologyEarly DetectionImmunotherapyRheumatologyLatent Tuberculosis InfectionPsoriatic ArthritisTuberculosis CareTuberculosis DiagnosisTuberculosis Diagnostic TestingTuberculosis PreventionLatent Tuberculosis Infection ScreeningLatent Tuberculosis ScreeningMycobacterium Tuberculosis InfectionPsoriasis TherapyScreening Algorithm DesignScreening Algorithm DevelopmentTuberculosis ChemoprophylaxisTuberculosis Screening
The biologic agents can be highly efficacious in the treatment of psoriasis and psoriatic arthritis; however, their use is associated with an increased risk of developing active TB. In particular, TNF-α plays critical role in preventing TB infection and reactivation of latent TB infection (LTBI). Therefore, it is critical that all patients be screened for LTBI prior to initiating therapy. An expert panel of Italian dermatologists met recently with the goal of producing a consensus paper on screening and chemoprophylaxis for LTBI in Italian psoriasis patients treated with biologics. Current recommendations for the screening algorithm include medical history, chest x-ray, and tests that evaluate immunologic response to the presence of Mycobacterium tuberculosis. Patients with positive screening results and without active disease are to be treated with a full course of chemoprophylaxis; however, if the patient is compliant and tolerating the regimen, biologic therapy for psoriasis may be started after at least 1 month on prophylactic therapy when prompt control of disease is required.
23
Jonathan E. Kaplan, Constance A. Benson, King K. Holmes et al. · PsycEXTRA Dataset · 2009 · 1.4K citations
Juan J. Gómez‐Reino, Loreto Carmona, Vicente Rodríguez Valverde et al. · Arthritis & Rheumatism · 2003 · 1K citations